Luts & Greenleigh Group, Inc Illumina, Inc. Transaction History

Luts & Greenleigh Group, Inc

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 01, 2023	SELL	$128.91 - $192.44 $37,126 - $55,422	-288 Reduced 3.52%	7,896 $1.08 Billion
Q2 2023 Jul 17, 2023	SELL	$183.43 - $232.67 $6,603 - $8,376	-36 Reduced 0.44%	8,184 $1.53 Billion
Q1 2023 Apr 13, 2023	BUY	$193.75 - $232.55 $9,687 - $11,627	50 Added 0.61%	8,220 $1.91 Billion
Q4 2022 Mar 30, 2023	BUY	$187.24 - $242.74 $1.53 Million - $1.98 Million	8,170 New	8,170 $1.65 Billion

901

137M

1.22M

1.43M

Ticker ILMN
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 157,300,000
Market Cap $22.7B
Description
Illumina, Inc. provides sequencing and array-based solutions for genetic and genomic analysis. Its products and services serve customers in a range of markets enabling the adoption of genomic solutions in research and clinical settings for applications in the life sciences, oncology, reproductive health, agriculture, and other emerging segments....

Get notified when there are updates to the investment portfolio of Luts & Greenleigh Group, Inc, based on Form 13F filings with the SEC.

Stay updated on Luts & Greenleigh Group, Inc with notifications on news.